INDIVIDUAL REACTIONS FROM THE PERIPHERAL NERVOUS SYSTEM IN THE CONDITIONS OF THE COVID-19 PANDEMIC

DOI: https://doi.org/10.29296/25877305-2022-03-05
Issue: 
3
Year: 
2022

A. Raevskaya; A. Deryabin; Associate Professor I. Vyshlova, MD; Professor S. Karpov, MD
Stavropol State Medical University

During the ongoing pandemic, more and more neurologists are seeing patients who have had a new coronavirus infection. The authors are of the opinion that vaccination is the only right way to reduce the incidence and, as a result, mortality from COVID-19. This article provides information on clinical cases of possible complications from the peripheral nervous system after a new coronavirus infection COVID-19.

Keywords: 
neurology
COVID-19
new coronavirus infection
vaccination
Bell’s palsy
facial nerve neuritis



References: 
  1. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210. DOI: 10.33029/0206-4952-2021-42-3-198-210
  2. Fotuhi M., Ali M., Somayeh M. et al. Neurobiology of COVID-19. J Alzheimers Dis. 2020; 76 (1): 3–19. DOI: 10.3233/JAD-200581
  3. Shirshova E.V., Knaub V.V., Baklaushev V.P. Klinicheskij sluchaj sindroma Gijena–Barre, indutsirovannogo COVID-19. Klinicheskaja praktika. 2021; 12 (2): 110–8. DOI: 10.17816/clinpract72264
  4. Dzhanibekova M.B., Zvjagintseva E.M., Vyshlova I.A. i dr. Nevrologicheskie rasstrojstva, assotsiirovannye s COVID-19. Vestnik molodogo uchenogo. 2021; 10 (2): 87–94.
  5. Fedin A.I. Nevrologicheskaja klinicheskaja patologija, assotsiirovannaja s COVID-19. Nevrologija i nejrohirurgija. Vostochnaja Evropa. 2020; 10 (2): 312–29. DOI: 10.34883/PI.2020.2.2.024
  6. Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 54–8. DOI: 10.1016/j.ijid.2020.03.062
  7. Fernandez C.E., Franz C.K., Ko J.H. et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021; 298 (3): 117–30. DOI: 10.1148/radiol.202020-3116
  8. Andalib S., Biller J., Di Napoli M. et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021; 21 (3): 9. DOI: 10.10-07/s11910-021-01102-5
  9. Belopasov V.V., Zhuravleva E.N., Nugmanova N.P. i dr. Postkovidnye nevrologicheskie sindromy. Klinicheskaja praktika. 2021; 12 (2): 69–82. DOI: 10.17816/clinpract71137
  10. Statistika vaktsinatsii ot koronavirusa v Rossii. URL: https://coronavirus-control.ru/statistika-vakczinaczii/
  11. Pojasnitel'naja zapiska po vaktsine ot COVID-19. Moderna, vaktsina ot COVID-19 (mRNK-1273). Vsemirnaja organizatsija zdravoohranenija. URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21100_russian_moderna-vaccine-explainer.pdf?sfvrsn=750f0e1f_5
  12. Pojasnitel'naja zapiska po vaktsine ot COVID-19. ChAdOx1-S [rekombinantnaja] vaktsina ot COVID-19. Vsemirnaja organizatsija zdravoohranenija. URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21102_russian_astrazeneca_vaccine-explainer13b2736d-2427-4c9e-bd3c-0e8d8e1511dc.pdf?sfvrsn=ec951194_5
  13. Ber M., Frotsher M. Topicheskij diagnoz v nevrologii po Peteru Duusu: anatomija, fiziologija, klinika. Per. s angl. pod red. O.S. Levina. 3-e izd. M.: Prakticheskaja meditsina, 2018; s. 205–6.
  14. Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med. 2004; 350 (9): 896–903. DOI: 10.1056/NEJMoa030595
  15. Iftikhar H. et al. Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine. Cureus. 2021; 13 (6): e15935. DOI: 10.7759/cureus.15935
  16. Ozonoff A., Nanishi E., Levy O. Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021; 21 (4): 450–2. DOI: 10.1016/S1473-3099(21)00076-1
  17. Burrows A. et al. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ case reports. 2021; 14 (7): e243829. DOI: 10.1136/bcr-2021-243829
  18. FDA. FDA Briefing document Pfizer-BioNTech Covid-19 Vaccine [Internet], 2020. URL: https://www.fda.gov/media/144245/download
  19. COVID-19 mRNA Pfizer-BioNTech vaccine analysis print [Internet]. Assets.publishing.service.gov.uk, 2021. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977005/COVID-19_mRNA_Pfizer-_BioNTech_Vaccine_Analysis_Print.pdf
  20. Kratkoe rukovodstvo. Vaktsinatsija protiv COVID-19 vaktsinoj CoronaVac kompanii Sinovac (Sinovac-CoronaVac). Vsemirnaja organizatsija zdravoohranenija. Evropejskoe regional'noe bjuro. URL: https://www.euro.who.int/__data/assets/pdf_file/0008/508760/Sinovac-quick-guide-COVID-19-rus.pdf
  21. Wan E.Y.F. et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet. Infect Dis. 2022; 22 (1): 64–72. DOI: 10.1016/S1473-3099(21)00451-5
  22. Shemer A., Pras E., Einan-Lifshitz A. et al. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2021; 147 (8): 739–43. DOI: 10.1001/jamaoto.2021.1259
  23. Volk G.F., Kuttenreich A.M., Geitner M. et al. Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2]. Laryngorhinootologie. 2021; 100 (7): 526–8. DOI: 10.1055/a-1501-0470
  24. Repajic M. et al. Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. 2021; 13: 100217. DOI: 10.1016/j.bbih.2021.100217
  25. Jung J., Park D.C., Jung S.Y. et al. Bilateral facial palsy. Acta Otolaryngol. 2019; 39 (10): 934–8. DOI: 10.1080/00016489.2019.1651134
  26. Mason M.C. et al. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence? Cureus. 2021; 13 (8): e17602. DOI: 10.7759/cureus.17602
  27. Dem'janovskaja E.G., Kryzhanovskij S.M., Vasil'ev A.S. i dr. Nevrologicheskie aspekty COVID-19. Taktika vedenija patsientov nevrologom s uchetom epidemiologicheskoj situatsii. Lechaschij Vrach. 2021; 2: 54–60. DOI: 10.26295/OS.2021.63.96.011
  28. Fasano A., Cavallieri F., Canali E. et al. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020; 41: 1651–3. DOI: 10.1007/s10072-020-04460-z
  29. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
  30. Kang L., Li Y., Hu S. et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020; 7 (3): e14. DOI: 10.1016/S 2215–0366(20)30047-X
  31. Zubair A.S., McAlpine L.S., Gardin T. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020; 77 (8): 1018–27. DOI: 10.1001/jamaneurol.2020.2065
  32. Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.) DOI: 10.33029/0206-4952-2021-42-3-198-210
  33. Fotuhi M., Ali M., Somayeh M. et al. Neurobiology of COVID-19. J Alzheimers Dis. 2020; 76 (1): 3–19. DOI: 10.3233/JAD-200581
  34. Shirshova E.V., Knaub V.V., Baklaushev V.P. A Clinical Case of Guillain–Barré Syndrome Associated with COVID-19. Journal of Clinical Practice. 2021; 12 (2): 110–8 (in Russ.). DOI: 10.17816/clinpract72264
  35. Dzhanibekova M.B., Zvyagintseva E.M., Vyshlova I.A. et al. Neurological disorders, associated with COVID-19. Vestnik molodogo uchenogo. 2021; 10 (2): 87–94 (in Russ.).
  36. Fedin A. Neurological clinical manifestations, associated with COVID-19. Nevrologiya i neirokhirurgiya. Vostochnaya Evropa. 2020; 10 (2): 312–29 (in Russ.). DOI: 10.34883/PI.2020.2.2.024
  37. Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 54–8. DOI: 10.1016/j.ijid.2020.03.062
  38. Fernandez C.E., Franz C.K., Ko J.H. et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021; 298 (3): 117–30. DOI: 10.1148/radiol.202020-3116
  39. Andalib S., Biller J., Di Napoli M. et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021; 21 (3): 9. DOI: 10.10-07/s11910-021-01102-5
  40. Belopasov V.V., Zhuravleva E.N., Nugmanova N.P. et al. Post-COVID-19 Neurological Syndromes. Journal of Clinical Practice. 2021; 12 (2): 69–82 (in Russ.). DOI: 10.17816/clinpract71137
  41. Statistika vaktsinatsii ot koronavirusa v Rossii (in Russ.). URL: https://coronavirus-control.ru/statistika-vakczinaczii/
  42. Poyasnitel’naya zapiska po vaktsine ot COVID-19. Moderna, vaktsina ot COVID-19 (mRNK-1273). WHO (in Russ.). URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21100_russian_moderna-vaccine-explainer.pdf?sfvrsn=750f0e1f_5
  43. Poyasnitel’naya zapiska po vaktsine ot COVID-19. ChAdOx1-S [rekombinantnaya] vaktsina ot COVID-19. WHO (in Russ.). [URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21102_russian_astrazeneca_vaccine-explainer13b2736d-2427-4c9e-bd3c-0e8d8e1511dc.pdf?sfvrsn=ec951194_5
  44. Ber M., Frotsher M. Topicheskii diagnoz v nevrologii po Peteru Duusu: anatomiya, fiziologiya, klinika. Per. s angl. pod red. O.S. Levina. 3-e izd. M.: Prakticheskaya meditsina, 2018; s. 205–6 (in Russ.).
  45. Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med. 2004; 350 (9): 896–903. DOI: 10.1056/NEJMoa030595
  46. Iftikhar H. et al. Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine. Cureus. 2021; 13 (6): e15935. DOI: 10.7759/cureus.15935
  47. Ozonoff A., Nanishi E., Levy O. Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021; 21 (4): 450–2. DOI: 10.1016/S1473-3099(21)00076-1
  48. Burrows A. et al. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ case reports. 2021; 14 (7): e243829. DOI: 10.1136/bcr-2021-243829
  49. FDA. FDA Briefing document Pfizer-BioNTech Covid-19 Vaccine [Internet], 2020. URL: https://www.fda.gov/media/144245/download
  50. COVID-19 mRNA Pfizer-BioNTech vaccine analysis print [Internet]. Assets.publishing.service.gov.uk, 2021. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977005/COVID-19_mRNA_Pfizer-_BioNTech_Vaccine_Analysis_Print.pdf
  51. Kratkoe rukovodstvo. Vaktsinatsiya protiv COVID-19 vaktsinoi CoronaVac kompanii Sinovac (Sinovac-CoronaVac). WHO (in Russ.). URL: https://www.euro.who.int/__data/assets/pdf_file/0008/508760/Sinovac-quick-guide-COVID-19-rus.pdf
  52. Wan E.Y.F. et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet. Infect Dis. 2022; 22 (1): 64–72. DOI: 10.1016/S1473-3099(21)00451-5
  53. Shemer A., Pras E., Einan-Lifshitz A. et al. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2021; 147 (8): 739–43. DOI: 10.1001/jamaoto.2021.1259
  54. Volk G.F., Kuttenreich A.M., Geitner M. et al. Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2]. Laryngorhinootologie. 2021; 100 (7): 526–8. DOI: 10.1055/a-1501-0470
  55. Repajic M. et al. Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. 2021; 13: 100217. DOI: 10.1016/j.bbih.2021.100217
  56. Jung J., Park D.C., Jung S.Y. et al. Bilateral facial palsy. Acta Otolaryngol. 2019; 39 (10): 934–8. DOI: 10.1080/00016489.2019.1651134
  57. Mason M.C. et al. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence? Cureus. 2021; 13 (8): e17602. DOI: 10.7759/cureus.17602
  58. Demianovskaia E.G., Kryzhanovskiy S.M., Vasiliev A.S. et al. Neurological aspects of COVID-19. Management of patients with neurological diseases considering epidemiological situation. Lechaschi Vrach. 2021; 2: 54–60 (in Russ.). DOI: 10.26295/OS.2021.63.96.011
  59. Fasano A., Cavallieri F., Canali E. et al. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020; 41: 1651–3. DOI: 10.1007/s10072-020-04460-z
  60. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
  61. Kang L., Li Y., Hu S. et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020; 7 (3): e14. DOI: 10.1016/S 2215–0366(20)30047-X
  62. Zubair A.S., McAlpine L.S., Gardin T. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020; 77 (8): 1018–27. DOI: 10.1001/jamaneurol.2020.2065